Source link : https://www.newshealth.biz/health-news/top-cancer-centers-phase-iii-win-in-prostate-cancer-screening-recs-for-anal-cancer/
U.S. News & World Report released its annual ranking of top cancer centers. Darolutamide (Nubeqa) plus androgen deprivation therapy (ADT) improved radiologic progression-free survival over ADT alone in metastatic hormone-sensitive prostate cancer in the ARANOTE trial, meeting the phase III study’s primary endpoint, Bayer announced. Meanwhile, results of the phase III TiNivo-2 trial in advanced […]
Author : News Health
Publish date : 2024-07-19 18:48:53
Copyright for syndicated content belongs to the linked Source.
Categories